Interchange Capital Partners, LLC Intellia Therapeutics, Inc. Transaction History

Interchange Capital Partners, LLC

$279 Million
Q3 2024

A detailed history of Interchange Capital Partners, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 20,284 shares of NTLA stock, worth $247,059. This represents 0.15% of its overall portfolio holdings.

Number of Shares

20,284

Previous 20,145 0.69%

Holding current value

$247,059

Previous $450,000 7.56%

% of portfolio

0.15%

Previous 0.17%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$19.72 - $27.36 $2,741 - $3,803	139 Added 0.69%	20,284 $416,000
Q2 2024 Jul 31, 2024	BUY	$20.02 - $27.22 $184,904 - $251,403	9,236 Added 84.66%	20,145 $450,000
Q1 2024 May 08, 2024	BUY	$23.82 - $32.8 $15,959 - $21,975	670 Added 6.54%	10,909 $300,000
Q4 2023 Jan 09, 2024	BUY	$23.16 - $32.34 $14,011 - $19,565	605 Added 6.28%	10,239 $312,000
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $23,240 - $33,648	735 Added 8.26%	9,634 $304,000
Q2 2023 Aug 08, 2023	SELL	$34.58 - $46.03 $108,200 - $144,027	-3,129 Reduced 26.01%	8,899 $362,000
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $400,532 - $539,094	12,028 New	12,028 $448,000
Q3 2022 Nov 07, 2022	SELL	$53.92 - $71.7 $45,184 - $60,084	-838 Reduced 9.6%	7,890 $441,000
Q2 2022 Aug 05, 2022	SELL	$38.49 - $76.21 $2,694 - $5,334	-70 Reduced 0.8%	8,728 $451,000
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $33,913 - $69,252	-582 Reduced 6.2%	8,798 $639,000
Q4 2021 Feb 04, 2022	BUY	$100.76 - $138.36 $119,803 - $164,510	1,189 Added 14.52%	9,380 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $57,845 - $77,252	437 Added 5.64%	8,191 $1.1 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $1.13 Million - $3.01 Million	-18,577 Reduced 70.55%	7,754 $1.26 Million
Q1 2021 May 05, 2021	SELL	$46.59 - $83.68 $147,643 - $265,181	-3,169 Reduced 10.74%	26,331 $2.19 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $555,485 - $1.87 Million	29,500 New	29,500 $1.6 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.

Account

Interchange Capital Partners, LLC Intellia Therapeutics, Inc. Transaction History